Communiqués Repligen Corporation

Actions

RGEN

US7599161095

Equipement, fournitures et distribution médicale

Marché Fermé - Nasdaq 22:00:00 12/10/2026			Varia. 5j.	Varia. 1 janv.
172,51 ^USD	-0,79 %		-8,97 %	+5,28 %

06/10	Un initié de Repligen a vendu des actions pour 1 036 654 dollars, selon un récent dépôt auprès de la SEC	MT
06/10	Repligen finalise l’acquisition de BioLife Solutions	MT

Communiqués

26/08	Repligen Corporation to Present at Wells Fargo 21st Annual Healthcare Conference	AQ
28/07	Repligen: Q2 Earnings Snapshot	AQ
28/07	Repligen Reports Second Quarter 2026 Financial Results and Updates Full Year 2026 Financial Guidance	AQ
15/07	Repligen to Report Second Quarter 2026 Financial Results	AQ
22/05	Repligen Corporation to Present at William Blair 46th Annual Growth Stock Conference	AQ
20/05	Repligen : 2025 Sustainability Report	PU
20/05	Repligen Announces Publication of the Company’s 2025 Corporate Sustainability Report	AQ
07/05	Repligen Corporation to Present at Bank of America Securities 2026 Global Healthcare Conference	AQ
05/05	Repligen: Q1 Earnings Snapshot	AQ
05/05	Repligen Reports First Quarter 2026 Financial Results and Updates Full Year 2026 Financial Guidance	AQ
22/04	Repligen to Report First Quarter 2026 Financial Results	AQ
17/04	Repligen Opens European Training & Innovation Center in Breda, Expanding Global Customer Support Network	AQ
05/03	Repligen Corporation to Present at Upcoming March Conferences	AQ
24/02	Repligen: Q4 Earnings Snapshot	AQ
24/02	Repligen Reports Fourth Quarter and Full Year 2025 Financial Results and Provides 2026 Financial Guidance	AQ
10/02	Repligen to Report Fourth Quarter and Full Year 2025 Financial Results	AQ
14/01	Repligen : J.P. Morgan 2026 Healthcare Conference Repligen Presentation - J.P. Morgan 2026 Healthcare Conference	PU
06/01	Repligen Executive Chair Tony Hunt to Retire; Dr. Martin D. Madaus Elected Chair	AQ
18/12	Repligen Corporation to Present at J.P. Morgan 2026 Healthcare Conference	AQ
16/12	Repligen Introduces Next-Generation Chromatography Resins to Advance New Modality Workflows	AQ
26/11	Repligen Corporation to Present at Evercore Healthcare Conference	AQ
04/11	Repligen Corporation to Present at Upcoming November Conferences	AQ
28/10/25	Repligen: Q3 Earnings Snapshot	AQ
28/10/25	Repligen Reports Third Quarter 2025 Financial Results and Updates Full Year 2025 Financial Guidance	AQ
15/10/25	Repligen to Report Third Quarter 2025 Financial Results	AQ